U.S. flag

An official website of the United States government

NM_000539.3(RHO):c.448G>A (p.Glu150Lys) AND Retinitis pigmentosa 4, autosomal recessive

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 4, 2006
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000013921.26

Allele description [Variation Report for NM_000539.3(RHO):c.448G>A (p.Glu150Lys)]

NM_000539.3(RHO):c.448G>A (p.Glu150Lys)

Gene:
RHO:rhodopsin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q22.1
Genomic location:
Preferred name:
NM_000539.3(RHO):c.448G>A (p.Glu150Lys)
Other names:
NP_000530.1:p.(Glu150Lys)
HGVS:
  • NC_000003.12:g.129530962G>A
  • NG_009115.1:g.7324G>A
  • NM_000539.3:c.448G>AMANE SELECT
  • NP_000530.1:p.Glu150Lys
  • NC_000003.11:g.129249805G>A
  • P08100:p.Glu150Lys
Protein change:
E150K; GLU150LYS
Links:
UniProtKB: P08100#VAR_004799; OMIM: 180380.0033; dbSNP: rs104893791
NCBI 1000 Genomes Browser:
rs104893791
Molecular consequence:
  • NM_000539.3:c.448G>A - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
Component leading to Loss-of-Function (LoF) [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0004]

Condition(s)

Name:
Retinitis pigmentosa 4, autosomal recessive
Identifiers:
MedGen: C4016366

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034168OMIM
no assertion criteria provided
Pathogenic
(Aug 4, 2006)
germlineliterature only

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Missense rhodopsin mutation in a family with recessive RP.

Kumaramanickavel G, Maw M, Denton MJ, John S, Srikumari CR, Orth U, Oehlmann R, Gal A.

Nat Genet. 1994 Sep;8(1):10-1. No abstract available.

PubMed [citation]
PMID:
7987385

Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin.

Macke JP, Davenport CM, Jacobson SG, Hennessey JC, Gonzalez-Fernandez F, Conway BP, Heckenlively J, Palmer R, Maumenee IH, Sieving P, et al.

Am J Hum Genet. 1993 Jul;53(1):80-9.

PubMed [citation]
PMID:
8317502
PMCID:
PMC1682214
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000034168.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (4)

Description

In an Indian family in which 5 of 9 sibs, the offspring of unaffected first-cousin parents, had retinitis pigmentosa (RP4; 613731), Kumaramanickavel et al. (1994) found a G-to-A transition at codon 150 of the RHP gene, predicted to lead to a change from glutamate (GAG) to lysine (AAG) in the gene product. The 4 patients available for study were homozygous for the E150K mutation and 2 of the unaffected 4 sibs were heterozygous. (In the diagram of the pedigree, the order of the sibs was deliberately scrambled to disguise the identity of the heterozygotes.) Glu150 forms part of the second cytoplasmic loop of rhodopsin. Of the more than 60 RP-causing rhodopsin mutations identified, only one, cys140-to-ser, was located in the cytoplasmic loop (Macke et al., 1993).

The E150K mutation in rhodopsin is located in its second cytoplasmic loop and is positioned at the rhodopsin dimer interface. Zhu et al. (2006) showed that neither global protein folding nor G-protein binding and activation by rhodopsin were significantly affected by the E150K mutation. However, E150K rhodopsin was aberrantly glycosylated and was retained in the cis/medial Golgi compartment. E150K rhodopsin did not alter plasma membrane targeting of wildtype rhodopsin in transfected HEK293 cells, and in the presence of excess wildtype rhodopsin, E150K rhodopsin was cotransported with wildtype rhodopsin through the trans-Golgi and delivered to the plasma membrane.

In a Turkish brother and sister with an unusual RP phenotype, Van Schil et al. (2016) identified homozygosity for the E150K mutation in the RHO gene. In addition, the sibs were homozygous for 4 noncoding variants in the SAMD7 gene (620493) that showed reduced activity compared to wildtype SAMD7 in luciferase experiments and electroporation assays in retinal explants. Their unaffected mother and 2 unaffected sisters were heterozygous for the RHO and SAMD7 variants, as was a brother with minor subclinical manifestations. The authors suggested that the unusual nummular intraretinal pigment deposits observed in the affected sibs might be attributed to the SAMD7 variants, and postulated the presence of other modifying factors to account for the heterozygous brother's manifestations.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 28, 2024